Rockville, MD—September 17th, 2024 —The BioHealth Capital Region Forum is honored to announce that Maryland Governor Wes Moore will attend the event this morning to deliver welcoming remarks between 9:00 am – 10:00 am. As the premier gathering for the biohealth industry in Maryland and the surrounding region, the Forum celebrates the significant contributions of this sector’s vitality and innovation landscape.
Governor Moore’s presence underscores the importance of the biohealth industry to Maryland and highlights his administration’s commitment to supporting this vital sector. “We are thrilled to welcome Governor Moore to the BioHealth Capital Region Forum. His continued support plays a crucial role in our mission to advance Maryland as a top biohealth hub in the country,” said Rich Bendis, President and CEO of BioHealth Innovation, Inc.
About Governor Wes Moore: Wes Moore is the 63rd Governor of Maryland and the state’s first Black Governor. A dedicated public servant with a notable military and academic background, including roles as a White House Fellow and CEO of the Robin Hood Foundation, Governor Moore has a long-standing commitment to social equity and economic opportunity. His career is marked by his leadership in enhancing educational and economic prospects for underserved communities.
About BioHealth Innovation, Inc.: BioHealth Innovation, Inc. (BHI) is a public-private nonprofit organization dedicated to accelerating biohealth commercialization in the BioHealth Capital Region, which encompasses Maryland, Washington D.C., and Virginia. BHI connects market-relevant research with early-stage capital and implements strategies that bring together federal, state, and private sector stakeholders to develop the next generation of biohealth industry leaders. For more information, please visit www.BioHealthInnovation.org.
About the BioHealth Capital Region: The BioHealth Capital Region (BHCR) is renowned for its vibrant ecosystem of innovation, education, and scientific research, making it a top three biohealth cluster in the United States. This region is a dynamic hub where academic institutions, government agencies, and private sector companies converge to drive advancements in biotechnology, pharmaceuticals, diagnostics, and health IT.